About

ECTOSCAN IS Revolutionizing Imaging Technology

EctoScan is leading the charge in medical and non-medical imaging innovations, with a robust portfolio of patented technologies that set us apart in the market. We’re inviting investors to join us in revolutionizing diagnostics and data collection across various industries. With successful funding, we can accelerate development, scale operations, and introduce our cutting-edge solutions to the global market.

Current Offering

EctoScan™ is raising up to $3.5 million to fund critical operations, including the completion of our EctoScan™ App for both iPhone and Android platforms. The investment will be allocated to:

App design, development, and testing
Commercial readiness
Market launch
Preparation for the follow-on offering

EctoScan's Key Strengths

Innovative Technology: Our patented multi-modal 3D scanning technology is set to revolutionize imaging across multiple sectors, with 7 issued patents and more in the pipeline, covering all key aspects of our technology and ensuring long-term market protection.
Growing Market: The demand for accurate, portable imaging solutions is rapidly increasing in both medical and consumer markets.
Proven Expertise: With over 20 years of experience in imaging technology, our team ensures high-quality, reliable solutions.
Revenue Potential: Independent forecasts predict EctoScan’s revenues reaching into the hundreds of millions of dollars annually.
Global Impact: Our technology is designed to be accessible and affordable, making it ideal for use in remote, underserved, or third-world areas.
Strong Intellectual Property: Our portfolio includes seven issued patents, such as Patent No. 7226426, which covers broad claims on systems measuring cardinal signs of inflammation, and Patent No. 11544852, focused on performance scanning system and method for improving athletic performance. These patents fortify our competitive edge and offer significant licensing and strategic partnership opportunities.

IP Strategy: Own the Vertical

Follow-on Offering

Following this round, EctoScan will seek an additional $5 million to complete the development and marketing of our standalone technology, further enhancing our market position and commercial reach.